Vikas Srinivasan Sridhar

24PUBLICATIONS
100CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsGastroenterology and hepatologyFood properties (incl. characteristics and health benefits)Podiatry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Luxcia Kugathasan, Massimo Nardone, Marcel H A Muskiet

|Jan 22, 2026
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.

Ayodele Odutayo, Deepak L Bhatt, Vikas S Sridhar

|Dec 12, 2025
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Vikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn

|Jun 26, 2025
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney Disease.

Kevin Yau, Joel G Ray, Nivethika Jeyakumar

|May 30, 2025
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

Jelle M Beernink, Niels Jongs, Charlotte M Mosterd

|Sep 02, 2024
Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.

Vikas S Sridhar, Francesco Cosentino, Samuel Dagogo-Jack

Pageof 4

Frequent Collaborators

11 joint publications

David Z I Cherney

7 joint publications

Luxcia Kugathasan

6 joint publications

Ayodele Odutayo

5 joint publications

Leif Erik Lovblom